Your browser doesn't support javascript.
loading
Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: a post-marketing surveillance study.
Bravo, Lulu; Chitraka, Amarjeet; Liu, Aixue; Choudhury, Jaydeep; Kumar, Kishore; Berezo, Lennie; Cimafranca, Leonard; Chatterjee, Pallab; Garg, Pankaj; Siriwardene, Prasanna; Bernardo, Rommel; Mehta, Shailesh; Balasubramanian, Sundaram; Karkada, Naveen; Htay Han, Htay.
Affiliation
  • Bravo L; a National Institutes of Health-University of The Philippines Manila; Manila, The Philippines.
Hum Vaccin Immunother ; 10(8): 2276-83, 2014.
Article in En | MEDLINE | ID: mdl-25424932
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Rotavirus Infections / Rotavirus Vaccines / Drug-Related Side Effects and Adverse Reactions Type of study: Clinical_trials / Prevalence_studies / Risk_factors_studies / Screening_studies Limits: Humans / Infant / Male / Newborn Country/Region as subject: Asia Language: En Journal: Hum Vaccin Immunother Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Rotavirus Infections / Rotavirus Vaccines / Drug-Related Side Effects and Adverse Reactions Type of study: Clinical_trials / Prevalence_studies / Risk_factors_studies / Screening_studies Limits: Humans / Infant / Male / Newborn Country/Region as subject: Asia Language: En Journal: Hum Vaccin Immunother Year: 2014 Document type: Article Country of publication: United States